AnazaoHealth Overview
- Founded
-
1997

- Status
-
Acquired/Merged
- Employees
-
75

- Latest Deal Type
-
M&A
- Financing Rounds
-
1
- Investments
-
1
AnazaoHealth General Information
Description
Operator of a specialty compounding pharmacy intended to serve nuclear medicine and pain management pharmacy markets. The company develops patient-specific medicines and compounds preparations for age management, weight management, intravenous therapy, sexual health, vitamin injections, hormone replacement, hair care solutions and aesthetics.
Contact Information
Website
www.anazaohealth.com
Formerly Known As
Custom Care Pharmacy
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Parent Company
Primary Office
- 5710 Hoover Boulevard
- Tampa, FL 33634
- United States
+1 (800) 000-0000
AnazaoHealth Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
AnazaoHealth Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Operator of a specialty compounding pharmacy intended to serve nuclear medicine and pain management pharmacy markets. Th
Pharmaceuticals
Tampa, FL
75
As of 2015
00.00
0000-00-00
000000&0
AnazaoHealth Competitors (5)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
CF PharmTech | Venture Capital-Backed | Suzhou, China | 000 | 00000 | 00000000 | 00000 |
0000000 0000000000 | Private Equity-Backed | West Columbia, SC | 0000 | 00000 | 000000000 00 | 00000 |
00000 00000000 000 | Private Equity-Backed | Northwood, OH | 0000 | 000.00 | 000000000 | 000.00 |
00000000 | Private Equity-Backed | Burton upon Trent, United Kingdom | 0000 | 0000 | 000000000000 | 0000 |
000000 | Corporation | Rotterdam, Netherlands | 0000 | 00000 | 000000000 | 00000 |
AnazaoHealth Patents
AnazaoHealth Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20080118433-A1 | Stabilized by lyophilization to prevent hydrolysis, autoradiolysis; higher purity and concentrations of radioisotope; iodine123 labeled chlorotoxin for diagnostics; iodine124 for treatment; shorter half-life, can be used cyclically; surgical implant, needle injection, iv for treatment of tumors | Inactive | 22-Oct-2004 | 0000000000 | |
CA-2571265-A1 | Stabilized and lyophilized radiopharmaceutical agents for destroying tumors | Inactive | 17-Jun-2004 | 000000000 | |
EP-1765419-A1 | Stabilized and lyophilized radiopharmaceutical agents for destroying tumors | Inactive | 17-Jun-2004 | 000000000 | |
EP-1765419-A4 | Stabilized and lyophilized radiopharmaceutical agents for destroying tumors | Inactive | 17-Jun-2004 | 000000000 | 0 |
JP-2008503493-A | Stabilized lyophilized radiopharmaceutical for tumor destruction | Pending | 17-Jun-2004 | A61K51/10 |
AnazaoHealth Executive Team (5)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Christopher Arnette | President and Chief Operating Officer | ||
Hal Weaver | President |
AnazaoHealth Signals
AnazaoHealth Acquisitions (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
000000 000000 | 02-Apr-2007 | 0000000000 | Pharmaceuticals | 00000 000 |